Skip to content

← All stories

Markets

Akari Therapeutics targets mid-2027 phase 1 trial for AKTX-101

1 source ·1 article ·1h ago Akari Therapeutics

Covered by 1 outlet

All coverage · 1 article

Investing.com News ·1h ago

Akari Therapeutics targets mid-2027 phase 1 trial for AKTX-101